Pasithea Therapeutics Stock Forecast - Period Momentum Indicator
| KTTA Stock | USD 5.06 0.20 3.80% |
Pasithea Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Pasithea Therapeutics stock prices and determine the direction of Pasithea Therapeutics Corp's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Pasithea Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
Pasithea |
Most investors in Pasithea Therapeutics cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Pasithea Therapeutics' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Pasithea Therapeutics' price structures and extracts relationships that further increase the generated results' accuracy.
Momentum indicator evaluates the difference between todays closing price and the close price n periods ago. It is the velocity with which the price is rising or falling. It also reflects how aggressively the asset is purchased or sold by the public.| Previous Period Momentum Indicator | Period Momentum Indicator | Trend |
| (2.74) | (2.34) |
| Check Pasithea Therapeutics Volatility | Backtest Pasithea Therapeutics | Trend Details |
Pasithea Therapeutics Trading Date Momentum
| On January 02 2024 Pasithea Therapeutics Corp was traded for 8.05 at the closing time. The top price for the day was 8.50 and the lowest listed price was 7.01 . The trading volume for the day was 113.4 K. The trading history from January 2, 2024 was a factor to the next trading day price jump. The trading delta at closing time against the next closing price was 8.78% . The trading delta at closing time against the current closing price is 4.32% . |
Generally speaking extended values of the momentum indicator over time are good indicators of oversold or over brought conditions.
| Compare Pasithea Therapeutics to competition |
Other Forecasting Options for Pasithea Therapeutics
For every potential investor in Pasithea, whether a beginner or expert, Pasithea Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Pasithea Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Pasithea. Basic forecasting techniques help filter out the noise by identifying Pasithea Therapeutics' price trends.View Pasithea Therapeutics Related Equities
| Risk & Return | Correlation |
Pasithea Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Pasithea Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Pasithea Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Pasithea Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Pasithea Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Pasithea Therapeutics shares will generate the highest return on investment. By undertsting and applying Pasithea Therapeutics stock market strength indicators, traders can identify Pasithea Therapeutics Corp entry and exit signals to maximize returns.
Pasithea Therapeutics Risk Indicators
The analysis of Pasithea Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Pasithea Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting pasithea stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.56 | |||
| Standard Deviation | 3.75 | |||
| Variance | 14.09 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in Pasithea Stock
When determining whether Pasithea Therapeutics is a strong investment it is important to analyze Pasithea Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pasithea Therapeutics' future performance. For an informed investment choice regarding Pasithea Stock, refer to the following important reports:Check out Historical Fundamental Analysis of Pasithea Therapeutics to cross-verify your projections. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pasithea Therapeutics. If investors know Pasithea will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pasithea Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (13.74) | Revenue Per Share 0.37 | Quarterly Revenue Growth 14.981 | Return On Assets (0.33) | Return On Equity (0.55) |
The market value of Pasithea Therapeutics is measured differently than its book value, which is the value of Pasithea that is recorded on the company's balance sheet. Investors also form their own opinion of Pasithea Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Pasithea Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pasithea Therapeutics' market value can be influenced by many factors that don't directly affect Pasithea Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pasithea Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pasithea Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pasithea Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.